|
S100PBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98060000000666E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.382870E-04 |
| Normal-vs-Stage2 |
6.10169999970545E-07 |
| Normal-vs-Stage3 |
2.32749999999893E-05 |
| Normal-vs-Stage4 |
1.395110E-04 |
| Stage1-vs-Stage2 |
1.118250E-02 |
| Stage1-vs-Stage3 |
1.794230E-01 |
| Stage1-vs-Stage4 |
4.127600E-01 |
| Stage2-vs-Stage3 |
1.731770E-01 |
| Stage2-vs-Stage4 |
1.276600E-01 |
| Stage3-vs-Stage4 |
8.342800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53249000000022E-05 |
| Normal-vs-AfricanAmerican |
4.737800E-02 |
| Normal-vs-Asian |
5.175700E-02 |
| Caucasian-vs-AfricanAmerican |
3.567400E-01 |
| Caucasian-vs-Asian |
1.107560E-01 |
| AfricanAmerican-vs-Asian |
8.048200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76740000001896E-06 |
| Normal-vs-Female |
1.96617999999038E-05 |
| Male-vs-Female |
4.146800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.441500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.24219999999109E-05 |
| Normal-vs-Age(61-80Yrs) |
4.76620000022798E-07 |
| Normal-vs-Age(81-100Yrs) |
1.324920E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.608550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.104310E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.014100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.868400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.223700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.573000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.653700E-02 |
| Classical-VS-Follicular |
9.28860000026788E-09 |
| Classical-VS-Other |
5.502400E-01 |
| Classical-VS-Normal |
1.062840E-03 |
| Tall-VS-Follicular |
1.106610E-01 |
| Tall-VS-Other |
7.020400E-01 |
| Tall-VS-Normal |
2.806600E-04 |
| Follicular-VS-Other |
2.359000E-01 |
| Follicular-VS-Normal |
1.50199996884481E-09 |
| Other-VS-Normal |
8.277800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.56610000026747E-07 |
| Normal-vs-N1 |
7.504600E-03 |
| N0-vs-N1 |
8.050200E-02 |
|
|
